If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Oral administration and ingestion of Baqsimi has not been studied in people with diabetes. As such, we have no information on the oral or buccal absorption of Baqsimi.
Glucagon for injection is not active when administered and ingested orally because it is a polypeptide that is destroyed in the gastrointestinal tract before it can be absorbed.2
Enclosed Prescribing Information
Baqsimi = Baqsimi™ (glucagon) nasal powder
Date of Last Review: August 23, 2019